Science ❯ Biotechnology

Therapeutics

Superkines Antibody Therapeutics Molecular Biology Cancer Therapies Chemical Research Early Stage Companies Monoclonal Antibodies Cancer Treatment Protein Engineering Preclinical Testing AI in Drug Development Antibody Design Regenerative Medicine

FDA Setback Puts uniQure’s Huntington’s Gene Therapy Filing in Doubt

The agency signaled that Phase I/II results versus external controls would not provide the primary evidence for a BLA.

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion

Frazier Life Sciences Closes $1.3 Billion Early-Stage Biotech Fund